Facebook
Linkedin
Tumblr
Twitter
Sign in
My Account
orders
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
Facebook
Linkedin
Tumblr
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
My Account
orders
Home
Tags
NASDAQ:BCLI
Tag: NASDAQ:BCLI
Brainstorm Cell Therapeutics Inc (NASDAQ:BCLI) price target set to $11.00 by...
ME Staff
-
July 24, 2018
0
Brainstorm Cell Therapeutics Inc (NASDAQ:BCLI) had its Buy rating reiterated by...
ME Staff
-
July 24, 2018
0
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Files An 8-K Entry into a...
ME Staff 8-k
-
June 7, 2018
0
Analyst Activity – HC Wainwright Initiates Coverage On NASDAQ:BCLI – Brainstorm...
ME Staff
-
May 15, 2018
0
Insider Trading Activity Brainstorm Cell Therapeutics (NASDAQ:BCLI) – Director Bought 5,700...
ME Staff
-
March 20, 2018
0
Insider Trading Activity Brainstorm Cell Therapeutics (NASDAQ:BCLI) – COO Bought 5,000...
ME Staff
-
March 20, 2018
0
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Files An 8-K Departure of Directors...
ME Staff 8-k
-
February 6, 2018
0
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Files An 8-K Other Events
ME Staff 8-k
-
January 4, 2018
0
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Files An 8-K Entry into a...
ME Staff 8-k
-
November 6, 2017
0
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Files An 8-K Entry into a...
ME Staff 8-k
-
July 26, 2017
0
1
2
3
Page 2 of 3
